The University of Chicago Header Logo

Connection

Satish Chitneni to Etanidazole

This is a "connection" page, showing publications Satish Chitneni has written about Etanidazole.
Connection Strength

1.911
  1. Reply: Pharmacokinetic and Pharmacodynamic Modifiers of EF5 Uptake and Binding. J Nucl Med. 2015 Apr; 56(4):653-4.
    View in: PubMed
    Score: 0.522
  2. Comparison of the Hypoxia PET Tracer (18)F-EF5 to Immunohistochemical Marker EF5 in 3 Different Human Tumor Xenograft Models. J Nucl Med. 2014 Jul; 55(7):1192-7.
    View in: PubMed
    Score: 0.494
  3. 18F-EF5 PET imaging as an early response biomarker for the hypoxia-activated prodrug SN30000 combined with radiation treatment in a non-small cell lung cancer xenograft model. J Nucl Med. 2013 Aug; 54(8):1339-46.
    View in: PubMed
    Score: 0.462
  4. A simplified synthesis of the hypoxia imaging agent 2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-[(18)F]pentafluoropropyl)-acetamide ([18F]EF5). Nucl Med Biol. 2012 Oct; 39(7):1012-8.
    View in: PubMed
    Score: 0.433
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.